Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 35 | 2024 | 1157 | 10.220 |
Why?
|
| Primary Health Care | 19 | 2024 | 348 | 5.430 |
Why?
|
| Diabetes Mellitus | 19 | 2023 | 743 | 4.380 |
Why?
|
| Hypoglycemic Agents | 13 | 2024 | 342 | 3.420 |
Why?
|
| Psychiatry | 4 | 2023 | 82 | 3.210 |
Why?
|
| Blood Glucose | 14 | 2024 | 839 | 3.040 |
Why?
|
| Depression | 9 | 2024 | 492 | 2.720 |
Why?
|
| Diabetes Complications | 11 | 2023 | 172 | 2.400 |
Why?
|
| Physicians | 7 | 2022 | 683 | 2.270 |
Why?
|
| Mass Screening | 7 | 2024 | 627 | 2.230 |
Why?
|
| Patient Portals | 2 | 2024 | 17 | 1.830 |
Why?
|
| Aging | 10 | 2023 | 702 | 1.790 |
Why?
|
| Medicaid | 7 | 2022 | 225 | 1.680 |
Why?
|
| Humans | 97 | 2024 | 87949 | 1.620 |
Why?
|
| Cost Sharing | 4 | 2024 | 16 | 1.520 |
Why?
|
| Mental Health Services | 2 | 2021 | 56 | 1.360 |
Why?
|
| Hypothyroidism | 4 | 2023 | 234 | 1.300 |
Why?
|
| Cardiovascular Diseases | 5 | 2023 | 697 | 1.240 |
Why?
|
| United States | 23 | 2024 | 6809 | 1.230 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 3 | 2023 | 33 | 1.230 |
Why?
|
| Nutrition Surveys | 7 | 2023 | 111 | 1.220 |
Why?
|
| Healthcare Disparities | 4 | 2022 | 390 | 1.200 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2021 | 59 | 1.200 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2019 | 66 | 1.160 |
Why?
|
| Documentation | 3 | 2022 | 103 | 1.160 |
Why?
|
| Depressive Disorder, Major | 2 | 2019 | 164 | 1.150 |
Why?
|
| Physicians, Primary Care | 2 | 2020 | 105 | 1.100 |
Why?
|
| Qualitative Research | 2 | 2024 | 279 | 0.990 |
Why?
|
| Adult | 27 | 2024 | 26131 | 0.950 |
Why?
|
| Cross-Sectional Studies | 15 | 2023 | 1682 | 0.950 |
Why?
|
| Chronic Disease | 4 | 2022 | 942 | 0.890 |
Why?
|
| Health Expenditures | 1 | 2024 | 90 | 0.880 |
Why?
|
| Anxiety | 2 | 2024 | 302 | 0.860 |
Why?
|
| Female | 42 | 2024 | 45399 | 0.850 |
Why?
|
| Insurance | 1 | 2022 | 12 | 0.850 |
Why?
|
| Hormone Replacement Therapy | 2 | 2022 | 78 | 0.840 |
Why?
|
| Population Health | 1 | 2022 | 33 | 0.840 |
Why?
|
| Aged | 31 | 2024 | 18750 | 0.830 |
Why?
|
| Middle Aged | 30 | 2024 | 25477 | 0.820 |
Why?
|
| Hyperthyroidism | 1 | 2022 | 75 | 0.820 |
Why?
|
| Male | 39 | 2024 | 41697 | 0.820 |
Why?
|
| Outpatients | 1 | 2022 | 98 | 0.810 |
Why?
|
| Systems Integration | 2 | 2021 | 36 | 0.810 |
Why?
|
| Schools, Medical | 1 | 2023 | 126 | 0.800 |
Why?
|
| Health Services Accessibility | 4 | 2021 | 411 | 0.800 |
Why?
|
| Hospitalization | 3 | 2021 | 864 | 0.790 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 221 | 0.780 |
Why?
|
| Referral and Consultation | 1 | 2024 | 339 | 0.780 |
Why?
|
| Quality of Life | 7 | 2021 | 1638 | 0.770 |
Why?
|
| Metformin | 1 | 2022 | 120 | 0.760 |
Why?
|
| Thyroid Hormones | 2 | 2023 | 326 | 0.750 |
Why?
|
| Quality-Adjusted Life Years | 6 | 2022 | 136 | 0.750 |
Why?
|
| Financing, Organized | 1 | 2020 | 12 | 0.730 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2020 | 24 | 0.720 |
Why?
|
| Breast Density | 1 | 2020 | 31 | 0.710 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 227 | 0.710 |
Why?
|
| State Health Plans | 1 | 2019 | 14 | 0.690 |
Why?
|
| Program Evaluation | 1 | 2020 | 302 | 0.670 |
Why?
|
| Hypertension | 3 | 2016 | 722 | 0.660 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 342 | 0.660 |
Why?
|
| Early Medical Intervention | 1 | 2018 | 19 | 0.650 |
Why?
|
| Quality of Health Care | 3 | 2022 | 384 | 0.640 |
Why?
|
| Veterans | 1 | 2019 | 83 | 0.640 |
Why?
|
| Cost-Benefit Analysis | 7 | 2022 | 453 | 0.630 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 268 | 0.620 |
Why?
|
| Community Health Centers | 2 | 2022 | 115 | 0.620 |
Why?
|
| Medicare | 4 | 2024 | 417 | 0.610 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 432 | 0.570 |
Why?
|
| Public Health | 2 | 2021 | 135 | 0.570 |
Why?
|
| Quality Improvement | 2 | 2017 | 433 | 0.560 |
Why?
|
| Health Policy | 2 | 2016 | 184 | 0.560 |
Why?
|
| Communication | 1 | 2020 | 448 | 0.550 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2016 | 3 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 561 | 0.540 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 333 | 0.540 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 407 | 0.540 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 498 | 0.540 |
Why?
|
| Patient Preference | 1 | 2016 | 108 | 0.530 |
Why?
|
| Coronavirus Infections | 1 | 2021 | 302 | 0.530 |
Why?
|
| HIV Infections | 1 | 2024 | 827 | 0.510 |
Why?
|
| Attitude to Health | 1 | 2016 | 221 | 0.510 |
Why?
|
| Glucose | 3 | 2022 | 628 | 0.510 |
Why?
|
| Insurance Coverage | 2 | 2019 | 117 | 0.500 |
Why?
|
| Medication Adherence | 1 | 2016 | 133 | 0.500 |
Why?
|
| Opioid-Related Disorders | 3 | 2022 | 177 | 0.500 |
Why?
|
| Surveys and Questionnaires | 9 | 2024 | 2574 | 0.500 |
Why?
|
| Risk Assessment | 4 | 2021 | 2274 | 0.480 |
Why?
|
| Leadership | 2 | 2017 | 136 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 1024 | 0.470 |
Why?
|
| Obesity | 2 | 2011 | 957 | 0.470 |
Why?
|
| Preventive Health Services | 1 | 2014 | 39 | 0.470 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 3650 | 0.460 |
Why?
|
| Health Care Reform | 2 | 2015 | 86 | 0.450 |
Why?
|
| Coronary Disease | 1 | 2014 | 258 | 0.430 |
Why?
|
| Bariatric Surgery | 2 | 2017 | 194 | 0.430 |
Why?
|
| Comorbidity | 5 | 2018 | 941 | 0.400 |
Why?
|
| Sodium | 2 | 2022 | 331 | 0.380 |
Why?
|
| Informed Consent | 2 | 2023 | 272 | 0.380 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 111 | 0.370 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 165 | 0.360 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2024 | 54 | 0.360 |
Why?
|
| Thyroxine | 4 | 2023 | 346 | 0.340 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 222 | 0.340 |
Why?
|
| Markov Chains | 2 | 2020 | 125 | 0.330 |
Why?
|
| Monte Carlo Method | 2 | 2020 | 186 | 0.320 |
Why?
|
| Models, Economic | 2 | 2020 | 60 | 0.320 |
Why?
|
| Life Expectancy | 3 | 2023 | 86 | 0.300 |
Why?
|
| Thyrotropin | 3 | 2023 | 285 | 0.300 |
Why?
|
| Risk Factors | 5 | 2024 | 5405 | 0.300 |
Why?
|
| Prospective Studies | 6 | 2023 | 4247 | 0.290 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 2740 | 0.270 |
Why?
|
| Appointments and Schedules | 2 | 2023 | 53 | 0.270 |
Why?
|
| Attitude of Health Personnel | 3 | 2022 | 642 | 0.270 |
Why?
|
| Chronic Pain | 2 | 2022 | 157 | 0.260 |
Why?
|
| Young Adult | 6 | 2019 | 6151 | 0.260 |
Why?
|
| Job Satisfaction | 2 | 2018 | 75 | 0.260 |
Why?
|
| Costs and Cost Analysis | 3 | 2020 | 155 | 0.250 |
Why?
|
| Triiodothyronine | 2 | 2023 | 340 | 0.250 |
Why?
|
| Health Care Surveys | 2 | 2019 | 280 | 0.250 |
Why?
|
| Retrospective Studies | 6 | 2024 | 8780 | 0.240 |
Why?
|
| Colorado | 1 | 2024 | 37 | 0.240 |
Why?
|
| Internship and Residency | 2 | 2011 | 1036 | 0.240 |
Why?
|
| Disease Progression | 3 | 2018 | 1479 | 0.240 |
Why?
|
| Efficiency | 2 | 2021 | 40 | 0.230 |
Why?
|
| Physician-Patient Relations | 3 | 2016 | 617 | 0.230 |
Why?
|
| Aged, 80 and over | 8 | 2024 | 6655 | 0.230 |
Why?
|
| California | 4 | 2024 | 143 | 0.230 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 89 | 0.220 |
Why?
|
| Parental Leave | 1 | 2023 | 9 | 0.220 |
Why?
|
| Logistic Models | 2 | 2019 | 1200 | 0.220 |
Why?
|
| Insurance, Health | 2 | 2015 | 157 | 0.220 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 4 | 0.220 |
Why?
|
| Prevalence | 2 | 2019 | 1247 | 0.220 |
Why?
|
| Faculty | 1 | 2023 | 32 | 0.220 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 433 | 0.210 |
Why?
|
| Academic Medical Centers | 3 | 2023 | 382 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 45 | 0.210 |
Why?
|
| Organizational Policy | 1 | 2023 | 55 | 0.210 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 129 | 0.210 |
Why?
|
| Fee-for-Service Plans | 1 | 2022 | 30 | 0.210 |
Why?
|
| Buprenorphine | 1 | 2022 | 38 | 0.210 |
Why?
|
| Waiting Lists | 1 | 2023 | 188 | 0.200 |
Why?
|
| Dementia | 1 | 2023 | 188 | 0.200 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2022 | 105 | 0.200 |
Why?
|
| Health Care Costs | 2 | 2020 | 232 | 0.190 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 104 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2020 | 861 | 0.180 |
Why?
|
| Computers | 1 | 2020 | 112 | 0.180 |
Why?
|
| Opiate Substitution Treatment | 1 | 2020 | 37 | 0.180 |
Why?
|
| Time Factors | 4 | 2021 | 5284 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 834 | 0.180 |
Why?
|
| Pandemics | 2 | 2023 | 757 | 0.180 |
Why?
|
| Fasting | 1 | 2020 | 163 | 0.180 |
Why?
|
| Emotions | 1 | 2023 | 348 | 0.180 |
Why?
|
| Hospitals | 1 | 2022 | 295 | 0.170 |
Why?
|
| Blood Pressure | 2 | 2015 | 885 | 0.170 |
Why?
|
| Interviews as Topic | 2 | 2019 | 333 | 0.170 |
Why?
|
| Length of Stay | 1 | 2022 | 716 | 0.170 |
Why?
|
| Withholding Treatment | 1 | 2019 | 113 | 0.160 |
Why?
|
| Demography | 2 | 2023 | 179 | 0.160 |
Why?
|
| Internal Medicine | 4 | 2021 | 356 | 0.160 |
Why?
|
| Insulin | 2 | 2023 | 1152 | 0.160 |
Why?
|
| Electronic Health Records | 2 | 2021 | 339 | 0.160 |
Why?
|
| Allied Health Personnel | 1 | 2018 | 20 | 0.160 |
Why?
|
| Work Engagement | 1 | 2017 | 6 | 0.160 |
Why?
|
| Health Status Disparities | 2 | 2023 | 175 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2023 | 2802 | 0.150 |
Why?
|
| Sepsis | 1 | 2021 | 313 | 0.150 |
Why?
|
| Inservice Training | 1 | 2017 | 38 | 0.150 |
Why?
|
| Urban Health Services | 1 | 2017 | 44 | 0.150 |
Why?
|
| Poverty | 1 | 2019 | 178 | 0.150 |
Why?
|
| Cost Savings | 1 | 2017 | 69 | 0.150 |
Why?
|
| Patient Participation | 1 | 2019 | 219 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2019 | 491 | 0.140 |
Why?
|
| Diet Therapy | 1 | 2016 | 20 | 0.140 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1037 | 0.140 |
Why?
|
| Financing, Personal | 1 | 2016 | 21 | 0.140 |
Why?
|
| Perception | 1 | 2017 | 176 | 0.140 |
Why?
|
| Linear Models | 2 | 2018 | 423 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2016 | 81 | 0.140 |
Why?
|
| Safety-net Providers | 1 | 2016 | 37 | 0.140 |
Why?
|
| Sexual and Gender Minorities | 1 | 2019 | 200 | 0.140 |
Why?
|
| Overweight | 1 | 2017 | 117 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 765 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2016 | 117 | 0.130 |
Why?
|
| Medical Overuse | 1 | 2016 | 36 | 0.130 |
Why?
|
| Life Style | 1 | 2016 | 172 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1827 | 0.130 |
Why?
|
| Phenotype | 1 | 2021 | 2424 | 0.130 |
Why?
|
| Data Accuracy | 1 | 2015 | 31 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 458 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2018 | 1539 | 0.120 |
Why?
|
| Federal Government | 1 | 2014 | 29 | 0.120 |
Why?
|
| Health Surveys | 2 | 2013 | 239 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2014 | 59 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2015 | 235 | 0.120 |
Why?
|
| Primary Prevention | 2 | 2013 | 79 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 223 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2018 | 1092 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 320 | 0.110 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 10 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 360 | 0.110 |
Why?
|
| Registries | 2 | 2013 | 743 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2017 | 765 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 682 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2022 | 8104 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 276 | 0.100 |
Why?
|
| Adolescent | 3 | 2019 | 9111 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 60 | 0.100 |
Why?
|
| United Kingdom | 1 | 2012 | 161 | 0.100 |
Why?
|
| Medical Audit | 1 | 2011 | 39 | 0.100 |
Why?
|
| Burnout, Professional | 1 | 2013 | 99 | 0.100 |
Why?
|
| Prognosis | 2 | 2016 | 3729 | 0.100 |
Why?
|
| Health Status | 2 | 2023 | 366 | 0.090 |
Why?
|
| Hypoglycemia | 1 | 2011 | 105 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2010 | 162 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 206 | 0.090 |
Why?
|
| Disease Management | 1 | 2011 | 328 | 0.080 |
Why?
|
| Counseling | 1 | 2009 | 159 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2019 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 966 | 0.070 |
Why?
|
| Chicago | 1 | 2011 | 1397 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 354 | 0.070 |
Why?
|
| Insulin Glargine | 1 | 2023 | 9 | 0.060 |
Why?
|
| Sulfonylurea Compounds | 1 | 2023 | 62 | 0.060 |
Why?
|
| Algorithms | 1 | 2011 | 1857 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2023 | 119 | 0.060 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2022 | 5 | 0.050 |
Why?
|
| Dronabinol | 1 | 2023 | 56 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 151 | 0.050 |
Why?
|
| Methadone | 1 | 2022 | 43 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2022 | 65 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.050 |
Why?
|
| Naltrexone | 1 | 2022 | 136 | 0.050 |
Why?
|
| Jurisprudence | 1 | 2021 | 25 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 366 | 0.050 |
Why?
|
| Community Networks | 1 | 2021 | 29 | 0.050 |
Why?
|
| Illinois | 1 | 2021 | 465 | 0.040 |
Why?
|
| Social Stigma | 1 | 2019 | 60 | 0.040 |
Why?
|
| Survival Rate | 2 | 2014 | 1877 | 0.040 |
Why?
|
| Economics, Medical | 1 | 2018 | 6 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 294 | 0.040 |
Why?
|
| Mental Health | 1 | 2019 | 171 | 0.040 |
Why?
|
| Checklist | 1 | 2018 | 57 | 0.040 |
Why?
|
| Australia | 1 | 2017 | 102 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2016 | 14 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 593 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2017 | 147 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 27028 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 224 | 0.030 |
Why?
|
| Philippines | 1 | 2015 | 22 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 51 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 49 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 593 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 572 | 0.030 |
Why?
|
| Clinical Audit | 1 | 2013 | 9 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1703 | 0.030 |
Why?
|
| New York City | 1 | 2013 | 60 | 0.030 |
Why?
|
| Midwestern United States | 1 | 2013 | 81 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 901 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2012 | 27 | 0.030 |
Why?
|
| Family Practice | 1 | 2013 | 85 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 994 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 172 | 0.030 |
Why?
|
| Age Distribution | 1 | 2012 | 200 | 0.030 |
Why?
|
| Medical Errors | 1 | 2013 | 116 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 2254 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 226 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1580 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1853 | 0.020 |
Why?
|
| Data Collection | 1 | 2009 | 374 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 323 | 0.020 |
Why?
|